Defining and targeting cardiac lipid dysregulation in Friedreich ataxia using human iPSC-derived cardiac models
|Nov 29 2025
Organelle-Specific Proteomic Profiling to Elucidate Mitochondrial Dysfunction and Therapeutic Mitochondrial Transfer in Friedreich’s Ataxia
|Nov 8 2025
Unravelling cell type sensitivity to frataxin depletion versus partial frataxin dysfunction using zebrafish models
|Nov 27 2024
Quantifying sitting balance in children and adults with Friedreich ataxia – development of clinical and instrumented measures
|Nov 17 2024
Design and synthesis of SynGR library to probe into the role of NSD-2,3 proteins in FXN expression in FRDA
|Nov 4 2024
Impact of cerebellar transcranial direct current stimulation on FA brain and cerebellar neurophysiological fingerprints and on clinical symptoms assessed by multimodal evaluations
|Nov 19 2023
Anatomical and functional analysis of corticospinal tract in FRDA mouse model
|Nov 19 2020
Cardiac benefit of drugs that stimulate Nrf2 and HCA2 pathways in Friedreich’s ataxia